πŸ‡ΊπŸ‡Έ FDA
Patent

US 9862693

Compounds and methods of treating cancer

granted A61KA61K31/155A61K31/4025

Quick answer

US patent 9862693 (Compounds and methods of treating cancer) held by The Regents of the University of California expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/155, A61K31/4025, A61K31/445, A61K31/4545